Home/HilleVax/Tara Fitzgerald
TF

Tara Fitzgerald

Chief Technical Officer

HilleVax

HilleVax Pipeline

DrugIndicationPhase
HIL-214Prevention of moderate-to-severe acute gastroenteritis caused by norovirus infectionPhase 2b/3